Is Aprea Therapeutics, Inc. stock a buy or sell right now?

Based on current indicators, Aprea Therapeutics, Inc. shows a Buy signal, supported by strong momentum and a confirmed uptrend.

What is Aprea Therapeutics, Inc.’s RSI?

RSI is 64.33, showing balanced momentum within the normal range.

What does MACD indicate for APRE?

MACD at 0.03 signals bullish momentum with buyers in control.

What are Aprea Therapeutics, Inc.’s key support and resistance levels?

Support sits around $0.58, while resistance is near $0.92. A breakout above $0.92 would open the door for further upside.

Aprea Therapeutics, Inc.

Get $10 bonus on your first $100 deposit for APRE

APRE•NASDAQ

Healthcare

Biotechnology

Get $10 bonus on your first $100 deposit for APRE

$0.94

$0.002(0.21%)

U.S. Market opens in 14h 45m

Aprea Therapeutics, Inc. (APRE) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Aprea Therapeutics, Inc. (NASDAQ:APRE).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

APRE Technical Analysis Summary

Aprea Therapeutics, Inc. stock currently shows a bullish trend, supported by momentum and strong buying pressure.

Overall Sentiment:Buy

Momentum:Bullish (RSI: 64.33)

Trend Strength:Moderate (ADX: 24.39)

Volatility:High (ATR: 0.10)

Support/Resistance:$0.58 – $0.92 (Bollinger Bands)

Technical conditions suggest Aprea Therapeutics, Inc. is consolidating, awaiting a decisive move.

Momentum Indicators

RSI (14): 64.33

Bullish

Above midpoint suggests upward bias.

Stochastic %K: 84.15

Bearish

Overbought levels may trigger pullback.

Williams %R: -7.00

Bearish

Overbought levels may trigger correction.

Rate of Change (ROC): 40.54

Strongly Bullish

Strong upside momentum.

Takeaway:Aprea Therapeutics, Inc. shows strong bullish momentum, with buyers firmly in control.

Trend & Volatility

MACD: 0.03

Bullish

Bullish, trend momentum is strengthening.

ADX: 24.39

Moderate

Moderate trend, direction gaining strength.

ATR (14): 0.10

Low

Low volatility, stable price action.

CCI (14): 156.07

Bearish Risk

Bearish risk, overbought levels suggest caution.

Takeaway:Aprea Therapeutics, Inc. shows a firm trend supported by momentum, though one signal suggests caution.

Support & Resistance indicators

Bollinger Bands

Upper Band

$0.92

Middle Band (SMA 20)

$0.75

Lower Band

$0.58

Current Position

Above Upper Band

Takeaway:Aprea Therapeutics, Inc. trades near the upper band, signaling overbought conditions and risk of pullback.

Keltner Channels

Upper Channel

$0.98

Middle Line (EMA 20)

$0.79

Lower Channel

$0.60

Squeeze Status

Squeeze On

Takeaway:Aprea Therapeutics, Inc. trades above the trend line, showing healthy momentum within the channel.

Volume & Money Flow Analysis

On-Balance Volume115.97M

Money Flow Index92.92Bearish risk, overbought conditions may trigger pullback.

Relative Vigor Index70.23Bullish, price momentum strongly favors buyers.

Overall Takeaway:APRE shows overheated money flow, with risk of pullback from overbought conditions.

Technical Trading Signals Summary

Based on the current technical analysis of Aprea Therapeutics, Inc., here are the key trading signals and recommendations:

Bullish Signals

RSI above 50 → positive momentum from buyers.

MACD above 0 → bullish trend confirmation.

ADX above 20 → strong underlying trend.

Price trading above middle Bollinger Band → mid-term support intact.

Bearish Signals

Price near upper Bollinger Band → potential resistance and pullback risk.

MFI above 80 → overbought conditions may limit upside.

Overall Recommendation:Aprea Therapeutics, Inc. currently shows a Buy with caution signal — momentum and trend strength are positive, but price is close to resistance and may face short-term pullbacks.